Skip Navigation


Carcinogenesis Advance Access originally published online on July 16, 2008
Carcinogenesis 2008 29(8):1614-1622; doi:10.1093/carcin/bgm234
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
29/8/1614    most recent
bgm234v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jin, Q.
Right arrow Articles by Lee, H.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jin, Q.
Right arrow Articles by Lee, H.-Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Survivin expression in normal human bronchial epithelial cells: an early and critical step in tumorigenesis induced by tobacco exposure

Quanri Jin, David G. Menter, Li Mao, Waun Ki Hong and Ho-Young Lee*

Department of Thoracic/Head and Neck Medical Oncology, Unit 432, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA

* To whom correspondence should be addressed. Tel: +1 713 792 6363; Fax: +1 713 796 8655; Email: hlee{at}mdanderson.org

The inhibitor of apoptosis protein survivin is selectively expressed in tumor cells. The tobacco component nicotine increases the transcription of the survivin gene in non-small cell lung cancer cells. However, the role of survivin expression induced by tobacco component is not clear during lung carcinogenesis. We investigated the effects of the tobacco components nicotine and its related carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) on survivin expression in normal human bronchial epithelial (NHBE) cells and examined the role of survivin in the malignant transformation of normal human bronchial epithelial (HBE) cells induced by these components. We found that survivin messenger RNA (mRNA) expression was detected in 41% (7 of 17) of bronchial brush specimens from heavy smokers. Nicotine and NNK increased survivin mRNA and protein expression levels in primary cultured NHBE cells and immortalized HBE cells. Bronchial epithelium in mice administered NNK also showed increased staining for survivin. Nicotine and NNK stimulated the Akt–mammalian target of rapamycin (mTOR) pathway in NHBE cells, leading to increased de novo synthesis of survivin protein. Induced survivin expression increased the survival potential of the cells, which was blocked by transfection with survivin-specific small interfering RNA (siRNA). siRNA-induced down-regulation of survivin expression also suppressed the tumorigenic potential of premalignant and malignant HBE cells exposed to the tobacco components. These findings suggest that NNK and nicotine induce survivin protein synthesis in NHBE cells by activating the Akt–mTOR pathway and thus blockade of the pathway effectively inhibits the tobacco-induced malignant transformation of HBE cells.

Abbreviations: BaP, benzo[a]pyrene; EGF, epidermal growth factor; HBE, human bronchial epithelial; IAP, inhibitor of apoptosis protein; KSFM, keratinocyte serum-free medium; MEF, mouse embryo fibroblast; mRNA, messenger RNA; mTOR, mammalian target of rapamycin; mut, mutant; NHBE, normal human bronchial epithelial; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; NSCLC, non-small cell lung cancer; pAkt, phosphorylated Akt; PI3K, phosphoinositol-3 kinase; siRNA, small interfering RNA; TSC2, tuberous sclerosis complex 2; WT, wild-type

Received July 6, 2007; revised October 10, 2007; accepted October 18, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
J. M. Rodenberg and P. H. Brown
A Novel Look into Estrogen Receptor-Negative Breast Cancer Prevention with the Natural, Multifunctional Signal Transduction Inhibitor Deguelin
Cancer Prevention Research, November 1, 2009; 2(11): 915 - 918.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.